Alexander M Choi, Michael J Brenner, Daniel Gorelik, Isaac D Erbele, Matthew G Crowson, Prajoy Kadkade, Masayoshi Takashima, Peter L Santa Maria, Robert S Hong, Austin S Rose, Benjamin T Ostrander, Cyrus C Rabbani, Robert J Morrison, Philip A Weissbrod, Alan D Tate, Joshua J Kain, Ioan A Lina, Scott R Shaffer, Omar G Ahmed
OBJECTIVE: To evaluate new medical devices and drugs pertinent to otolaryngology-head and neck surgery that were approved by the Food and Drug Administration (FDA) in 2021. DATA SOURCES: Publicly available FDA device and drug approvals from ENT (ear, nose, and throat), anesthesia, neurosurgery, plastic surgery, and general surgery FDA committees. REVIEW METHODS: FDA device and therapeutic approvals were identified and reviewed by members of the American Academy of Otolaryngology-Head and Neck Surgery's Medical Devices and Drugs Committee...
2022: OTO Open